The global neoantigen cancer vaccine market was valued at USD 116.74 million in 2023, and its growth trajectory is nothing short of remarkable. Over the forecast period of 2024-2032, the market is expected to expand at an astonishing compound annual growth rate (CAGR) of 69.43%, ultimately reaching an estimated value …
Read More »